Mitochondrial dysfunction in genetic animal models of Parkinson's disease

Antioxidants and Redox Signaling

Volumn 16, Issue 9, 2012, Pages 896-919

  Trancikova, Alzbeta ^a   Tsika, Elpida ^a   Moore, Darren J ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; DOPAMINE; LEUCINE RICH REPEAT KINASE 2; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

AUTOPHAGY; AUTOSOMAL RECESSIVE DISORDER; CAENORHABDITIS ELEGANS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DROSOPHILA; GENE FUNCTION; GENE MUTATION; GENETICS; IDIOPATHIC DISEASE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE MODELS, ANIMAL; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; PARKINSON DISEASE; PROTEIN KINASES; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 84857953098     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4200     Document Type: Review

References (214)

1. Alegre-Abarrategui J, Christian H, Lufino MMP, Mutihac R, Venda LL, Ansorge O, and Wade-Martins R. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 18: 4022-4034, 2009.
2. Andres-Mateos E, Mejias R, Sasaki M, Li X, Lin BM, Biskup S, Zhang L, Banerjee R, Thomas B, Yang L, Liu G, Beal MF, Huso DL, Dawson TM, and Dawson VL. Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). J Neurosci 29: 15846-15850, 2009.
3. Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, and Dawson VL. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA 104: 14807-14812, 2007. (Pubitemid 350003224)
4. Anichtchik O, Diekmann H, Fleming A, Roach A, Goldsmith P, and Rubinsztein DC. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 28: 8199-8207, 2008.
5. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, and Lees AJ. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127: 420-430, 2004. (Pubitemid 38160326)
6. Banerjee K, Sinha M, Pham CLL, Jana S, Chanda D, Cappai R, and Chakrabarti S. [alpha]-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS lett 584: 1571-1576, 2010.
7. Batelli S, Albani D, Rametta R, Polito L, Prato F, Pesaresi M, Negro A, and Forloni G. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS One 3: e1884, 2008.
8. Beal MF. Parkinson's disease: a model dilemma. Nature 466: S8-S10, 2010.
9. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, and Turnbull DM. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38: 515-517, 2006.
10. Berger Z, Smith KA, and LaVoie MJ. Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49: 5511-5523, 2010.
11. Berwick DC and Harvey K. LRRK2 signaling pathways: the key to unlocking neurodegeneration? Trends Cell Biol 21: 257-265, 2011.
12. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, and Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
13. Biskup S and Moore DJ. Detrimental deletions: mitochondria, aging and Parkinson's disease. BioEssays 28: 963-967, 2006. (Pubitemid 44570444)
14. Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu S-W, Savitt JM, Waldvogel HJ, Faull RLM, Emson PC, Torp R, Ottersen OP, Dawson TM, and Dawson VL. Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 60: 557-569, 2006. (Pubitemid 44871798)
15. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259, 2003. (Pubitemid 36131051)
16. Botella J, Bayersdorfer F, Gmeiner F, and Schneuwly S. Modelling Parkinson's disease in Drosophila. Neuromolecular Med 11: 268-280, 2009.
17. Bü eler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218: 235-246, 2009.
18. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, and Cookson MR. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101: 9103-9108, 2004. (Pubitemid 38781618)
19. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, and Chan DC. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20: 1726-1737, 2011.
20. Chinta SJ, Mallajosyula JK, Rane A, and Andersen JK. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486: 235-239, 2010.
21. Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, Kuum M, Zharkovsky A, and Kaasik A. Mutant A53T a-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 286: 10814-10824, 2011.
22. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, and Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166, 2006. (Pubitemid 43990738)
23. Cole NB, DiEuliis D, Leo P, Mitchell DC, and Nussbaum RL. Mitochondrial translocation of [alpha]-synuclein is promoted by intracellular acidification. Exp Cell Res 314: 2076-2089, 2008.
24. Conway KA, Harper JD, and Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4: 1318-1320, 1998. (Pubitemid 28512115)
25. Cookson MR. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11: 791-797, 2010.
26. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, LaBaer J, Rochet J-C, Bonini NM, and Lindquist S. {alpha}-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313: 324-328, 2006. (Pubitemid 44480951)
27. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, and Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305: 1292-1295, 2004. (Pubitemid 39129234)
28. Dä chsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, and Farrer MJ. A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord 16: 650-655, 2010.
29. Dagda RK, Cherra SJ, 3rd, Kulich SM, Tandon A, Park D, and Chu CT. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284: 13843-13855, 2009.
30. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, and Brice A. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12: 517-526, 2003. (Pubitemid 36305590)
31. Dauer W, Kholodilov N, Vila M, Trillat A-C, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, and Hen R. Resistance of a-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99: 14524-14529, 2002. (Pubitemid 35257704)
32. Dauer W and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39: 889-909, 2003. (Pubitemid 37130207)
33. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, and DiMauro S. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59: 859-862, 2006. (Pubitemid 43673164)
34. Dawson TM, Ko HS, and Dawson VL. Genetic animal models of Parkinson's disease. Neuron 66: 646-661, 2010.
35. Deng H, Dodson MW, Huang H, and Guo M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 105: 14503-14508, 2008.
36. Detmer SA and Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 8: 870-879, 2007. (Pubitemid 47622562)
37. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, and Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283: 9089-9100, 2008.
38. Dong Z, Ferger B, Paterna JC, Vogel D, Furler S, Osinde M, Feldon J, and Bueler H. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci USA 100: 12438-12443, 2003. (Pubitemid 37271578)
39. Dusonchet J, Kochubey O, Stafa K, Young SM, Jr., Zufferey R, Moore DJ, Schneider BL, and Aebischer P. A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. J Neurosci 31: 907-912, 2011.
40. Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A, Hoffer B, Cullheim S, Mohammed AH, Olson L, and Larsson NG. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 104: 1325-1330, 2007. (Pubitemid 46184003)
41. Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcelo-Coblijn GC, and Nussbaum RL. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking {alpha}-synuclein. Mol Cell Biol 25: 10190-10201, 2005. (Pubitemid 41572763)
42. Feany MB and Bender WW. A Drosophila model of Parkinson's disease. Nature 404: 394-398, 2000. (Pubitemid 30164341)
43. Forman MS, Lee VMY, and Trojanowski JQ. Nosology of Parkinson's disease: looking for the way out of a quackmire. Neuron 47: 479-482, 2005. (Pubitemid 41139206)
44. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, and Sudhof TC. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102: 3413-3418, 2005. (Pubitemid 40328059)
45. Forno LS, Langston JW, DeLanney LE, and Irwin I. An electron microscopic study of MPTP-induced inclusion bodies in an old monkey. Brain Res 448: 150-157, 1988.
46. Frederick RL and Shaw JM. Moving mitochondria: establishing distribution of an essential organelle. Traffic 8: 1668-1675, 2007. (Pubitemid 350066679)
47. Gandhi PN, Wang X, Zhu X, Chen SG, and Wilson-Delfosse AL. The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 86: 1711-1720, 2008. (Pubitemid 351859422)
48. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, and Abramov AY. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33: 627-638, 2009.
49. Gasser T. Mendelian forms of Parkinson's disease. Biochim Biophys Acta 1792: 587-596, 2009.
50. Gautier CA, Kitada T, and Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci USA 105: 11364-11369, 2008.
51. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, and Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19: 4861-4870, 2010.
52. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, and Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131, 2010.
53. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, and Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989, 2000.
54. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, and Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alphasynuclein. Neuron 34: 521-533, 2002. (Pubitemid 34628750)
55. Gillardon F. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability-a point of convergence in Parkinsonian neurodegeneration? J Neurochem 110: 1514-1522, 2009.
56. Gillardon F, Mack M, Rist W, Schnack C, Lenter M, Hildebrandt T, and Hengerer B. MicroRNA and proteome expression profiling in early-symptomatic a-synuclein( A30P)-transgenic mice. Proteomics Clin Appl 2: 697-705, 2008. (Pubitemid 351772025)
57. Glauser L, Sonnay S, Stafa K, and Moore DJ. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 118: 636-645, 2011.
58. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, and Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278: 43628-43635, 2003. (Pubitemid 37345989)
59. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bernardi G, Roth BL, Pothos EN, Calabresi P, and Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45: 489-496, 2005. (Pubitemid 40249861)
60. Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, and Giasson BI. The E46K mutation in alpha-synuclein increases amyloid fibril formation. J Biol Chem 280: 7800-7807, 2005. (Pubitemid 40349674)
61. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, and Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100: 4078-4083, 2003. (Pubitemid 36418160)
62. Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, and Cookson MR. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23: 329-341, 2006. (Pubitemid 44097032)
63. Gupta A, Dawson VL, and Dawson TM. What causes cell death in Parkinson's disease? Ann Neurol 64: S3-S15, 2008.
64. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, and Surmeier DJ. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468: 696-700, 2010.
65. Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, and Shults CW. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37: 714-722, 1995.
66. Harrington AJ, Hamamichi S, Caldwell GA, and Caldwell KA. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev Dyn 239: 1282-1295, 2010.
67. Henchcliffe C and Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neuro 4: 600-609, 2008.
68. Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D, Mulsch A, Nussbaum RL, Muller K, Drose S, Brandt U, Deller T, Wirth B, Kudin AP, Kunz WS, and Auburger G. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis 25: 401-411, 2007. (Pubitemid 46124020)
69. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, and Masliah E. Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157: 401-410, 2000. (Pubitemid 30627559)
70. Iaccarino C, Crosio C, Vitale C, Sanna G, Carr̀ MT, and Barone P. Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum Mol Genet 16: 1319-1326, 2007. (Pubitemid 47055127)
71. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, Laville M, Pratt J, Corti O, Pradier L, Ret G, Joubert C, Periquet M, Araujo F, Negroni J, Casarejos MJ, Canals S, Solano R, Serrano A, Gallego E, Sanchez M, Denefle P, Benavides J, Tremp G, Rooney TA, Brice A, and Garcia de Yebenes J. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12: 2277-2291, 2003. (Pubitemid 37160872)
72. Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A, and Alessi DR. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 405: 307-317, 2007. (Pubitemid 47075166)
73. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, and Youle RJ. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191: 933-942, 2010.
74. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, and Haass C. Inhibition of mitochondrial fusion by [alpha]-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29: 3571-3589, 2010.
75. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, and Mak TW. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102: 5215-5220, 2005.
76. Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, Kitada T, Kim JM, and Chung J. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377: 975-980, 2008.
77. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N, Mandel RJ, and Bjorklund A. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 22: 2780-2791, 2002. (Pubitemid 37465827)
78. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608, 1998. (Pubitemid 28207717)
79. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, and Shen J. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA 104: 11441-11446, 2007. (Pubitemid 47175159)
80. Kitada T, Tong Y, Gautier CA, and Shen J. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J Neurochem 111: 696-702, 2009.
81. Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, and Beal MF. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 21: 541-548, 2006. (Pubitemid 43277537)
82. Knott AB, Perkins G, Schwarzenbacher R, and Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9: 505-518, 2008. (Pubitemid 351873464)
83. Ko HS, Kim SW, Sriram SR, Dawson VL, and Dawson TM. Identification of far upstream element-binding protein-1 as an authentic Parkin substrate. J Biol Chem 281: 16193-16196, 2006.
84. Ko HS, von Coelln R, Sriram SR, Kim SW, Chung KK, Pletnikova O, Troncoso J, Johnson B, Saffary R, Goh EL, Song H, Park BJ, Kim MJ, Kim S, Dawson VL, and Dawson TM. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci 25: 7968-7978, 2005. (Pubitemid 41254399)
85. Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, and Ferrante RJ. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11: 211-213, 2000. (Pubitemid 30053420)
86. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, and Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38: 518-520, 2006.
87. Kruger R, Sharma M, Riess O, Gasser T, Van Broeckhoven C, Theuns J, Aasly J, Annesi G, Bentivoglio AR, Brice A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Klein C, Lambert JC, Lesage S, Lin JJ, Lynch T, Mellick GD, de Nigris F, Opala G, Prigione A, Quattrone A, Ross OA, Satake W, Silburn PA, Tan EK, Toda T, Tomiyama H, Wirdefeldt K, Wszolek Z, Xiromerisiou G, and Maraganore DM. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging 32: 548, e9-e18, 2011.
88. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, and Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484, 2005. (Pubitemid 40994689)
89. Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, and Matsumoto T. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15: 883-895, 2006. (Pubitemid 43338230)
90. Lang AE and Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 339: 1044-1053, 1998. (Pubitemid 28457867)
91. Lang AE and Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 339: 1130-1143, 1998. (Pubitemid 28465762)
92. Langston JW, Ballard P, Tetrud JW, and Irwin I. Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science 219: 979-980, 1983. (Pubitemid 13189531)
93. Lee BD, Shin J-H, VanKampen J, Petrucelli L, West AB, Ko HS, Lee Y-I, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, and Dawson TM. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 16: 998-1000, 2010.
94. Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, and Price DL. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53-Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99: 8968-8973, 2002. (Pubitemid 34693667)
95. Li W-W, Yang R, Guo J-C, Ren H-M, Zha X-L, Cheng J-S, and Cai D-F. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18: 1543-1546, 2007. (Pubitemid 47476380)
96. Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, Buxbaum JD, Elder GA, Rice ME, and Yue Z. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 30: 1788-1797, 2010.
97. Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, and Li C. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12: 826-828, 2009.
98. Li Z, Okamoto K, Hayashi Y, and Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887, 2004. (Pubitemid 40017692)
99. Lin X, Parisiadou L, Gu X-L, Wang L, Shim H, Sun L, Xie C, Long C-X, Yang W-J, Ding J, Chen ZZ, Gallant PE, Tao-Cheng J-H, Rudow G, Troncoso JC, Liu Z, Li Z, and Cai H. Leucine-Rich Repeat Kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant [alpha]-synuclein. Neuron 64: 807-827, 2009.
100. Liu Z, Wang X, Yu Y, Li X, Wang T, Jiang H, Ren Q, Jiao Y, Sawa A, Moran T, Ross CA, Montell C, and Smith WW. A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci USA 105: 2693-2698, 2008. (Pubitemid 351520575)
101. Loeb V, Yakunin E, Saada A, and Sharon R. The transgenic overexpression of a-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem 285: 7334-7343, 2010.
102. Lotharius J and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3: 932-942, 2002.
103. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y, and Brice A. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 342: 1560-1567, 2000. (Pubitemid 30340501)
104. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lammermann K, Brunner B, Kurz-Drexler A, Vogel F, Reichert AS, Bouman L, Vogt-Weisenhorn D, Wurst W, Tatzelt J, Haass C, and Winklhofer KF. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284: 22938-22951, 2009.
105. MacAskill AF and Kittler JT. Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20: 102-112, 2010.
106. Macedo MG, Anar B, Bronner IF, Cannella M, Squitieri F, Bonifati V, Hoogeveen A, Heutink P, and Rizzu P. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum Mol Genet 12: 2807-2816, 2003. (Pubitemid 37407117)
107. MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, and Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52: 587-593, 2006. (Pubitemid 44781171)
108. Maroteaux L, Campanelli JT, and Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8: 2804-2815, 1988.
109. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, and Lee MK. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26: 41-50, 2006. (Pubitemid 43089519)
110. Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, and Cuervo AM. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118: 777-788, 2008.
111. Melrose HL, Dä chsel JC, Behrouz B, Lincoln SJ, Yue M, Hinkle KM, Kent CB, Korvatska E, Taylor JP, Witten L, Liang YQ, Beevers JE, Boules M, Dugger BN, Serna VA, Gaukhman A, Yu X, Castanedes-Casey M, Braithwaite AT, Ogholikhan S, Yu N, Bass D, Tyndall G, Schellenberg GD, Dickson DW, Janus C, and Farrer MJ. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40: 503-517, 2010.
112. Menzies FM, Yenisetti SC, and Min KT. Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr Biol 15: 1578-1582, 2005. (Pubitemid 41219598)
113. Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, and Bonini NM. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol 15: 1572-1577, 2005. (Pubitemid 41219597)
114. Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, McLendon C, Carter DM, Zhu PP, Stadler J, Chandran J, Klinefelter GR, Blackstone C, and Cookson MR. L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 278: 36588-36595, 2003. (Pubitemid 37139990)
115. Moore D and Dawson T. Value of genetic models in understanding the cause and mechanisms of Parkinson's disease. Curr Neurol Neurosci Rep 8: 288-296, 2008.
116. Moore DJ. Parkin: a multifaceted ubiquitin ligase. Biochem Soc Trans 34: 749-753, 2006. (Pubitemid 44796412)
117. Moore DJ. The biology and pathobiology of LRRK2: implications for Parkinson's disease. Parkinsonism Relat Disord 14 Suppl 2: S92-S98, 2008.
118. Moore DJ, Dawson VL, and Dawson TM. Lessons from Drosophila models of DJ-1 deficiency. Sci Aging Knowledge Environ 2006: pe2, 2006.
119. Moore DJ, West AB, Dawson VL, and Dawson TM. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28: 57-87, 2005. (Pubitemid 41098899)
120. Moore DJ, Zhang L, Dawson TM, and Dawson VL. A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J Neurochem 87: 1558-1567, 2003. (Pubitemid 38020589)
121. Mortiboys H, Johansen KK, Aasly JO, and Bandmann O. Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 75: 2017-2020, 2010.
122. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, and Bandmann O. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64: 555-565, 2008.
123. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogus H, Dalkara T, and Ozer N. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19: 544-548, 2004.
124. Murakami T, Shoji M, Imai Y, Inoue H, Kawarabayashi T, Matsubara E, Harigaya Y, Sasaki A, Takahashi R, and Abe K. Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann Neurol 55: 439-442, 2004. (Pubitemid 38269599)
125. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, and Edwards RH. Direct membrane association drives mitochondrial fission by the Parkinson diseaseassociated protein a-synuclein. J Biol Chem 286: 20710-20726, 2011.
126. Narendra D, Kane LA, Hauser DN, Fearnley IM, and Youle RJ. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6: 1090-1106, 2010.
127. Narendra D, Tanaka A, Suen DF, and Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803, 2008.
128. Narendra D, Tanaka A, Suen DF, and Youle RJ. Parkininduced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5: 706-708, 2009.
129. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, and Youle RJ. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298, 2010.
130. Ng C-H, Mok SZS, Koh C, Ouyang X, Fivaz ML, Tan E-K, Dawson VL, Dawson TM, Yu F, and Lim K-L. Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 29: 11257-11262, 2009.
131. Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T, Ribe E, Ferrer I, RamÌrez MJ, and Gomez-Isla T. Increased sensitivity to MPTP in human [alpha]-synuclein A30P transgenic mice. Neurobiol Aging 27: 848-856, 2006.
132. Okatsu K, Saisho K, Shimanuki M, Nakada K, Shitara H, Sou YS, Kimura M, Sato S, Hattori N, Komatsu M, Tanaka K, and Matsuda N. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells 15: 887-900, 2010.
133. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, and Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279: 18614-18622, 2004. (Pubitemid 38623283)
134. Parihar M, Parihar A, Fujita M, Hashimoto M, and Ghafourifar P. Mitochondrial association of alphasynuclein causes oxidative stress. Cell Mol Life Sci 65: 1272-1284, 2008.
135. Parisiadou L, Xie C, Cho HJ, Lin X, Gu X-L, Long C-X, Lobbestael E, Baekelandt V, Taymans J-M, Sun L, and Cai H. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29: 13971-13980, 2009.
136. Park J, Kim SY, Cha GH, Lee SB, Kim S, and Chung J. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361: 133-139, 2005. (Pubitemid 41506941)
137. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, and Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161, 2006. (Pubitemid 43990737)
138. Parker WD, Jr., Parks JK, and Swerdlow RH. Complex I deficiency in Parkinson's disease frontal cortex. Brain Res 1189: 215-8, 2008. (Pubitemid 351842538)
139. Periquet M, Corti O, Jacquier S, and Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 95: 1259-1276, 2005. (Pubitemid 41779252)
140. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, Harding M, Bellen H, and Mardon G. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131: 2183-2194, 2004. (Pubitemid 38702049)
141. Plowey ED, Cherra SJ, Liu Y-J, and Chu CT. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105: 1048-1056, 2008. (Pubitemid 351565713)
142. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, and Downward J. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9: 1243-1252, 2007. (Pubitemid 350042356)
143. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, and Pallanck LJ. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 105: 1638-1643, 2008. (Pubitemid 351346567)
144. Poole AC, Thomas RE, Yu S, Vincow ES, and Pallanck L. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 5: e10054, 2010.
145. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, and Butterfield DA. Mitochondrial associated metabolic proteins are selectively oxidized in A30P [alpha]-synuclein transgenic mice-a model of familial Parkinson's disease. Neurobiol Dis 18: 492-498, 2005. (Pubitemid 40332708)
146. Pridgeon JW, Olzmann JA, Chin LS, and Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5: e172, 2007.
147. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, and Klein C. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS One 6: e16746, 2011.
148. Ramonet D, Daher JPL, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L, Liu Y, Swing DA, Beal MF, Troncoso JC, McCaffery JM, Jenkins NA, Copeland NG, Galter D, Thomas B, Lee MK, Dawson TM, Dawson VL, and Moore DJ. Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One 6: e18568, 2011.
149. Ramsey CP, Tsika E, Ischiropoulos H, and Giasson BI. DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity. Hum Mol Genet 19: 1425-1437, 2010.
150. Rathke-Hartlieb S, Kahle PJ, Neumann M, Ozmen L, Haid S, Okochi M, Haass C, and Schulz JB. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J Neurochem 77: 1181-1184, 2001. (Pubitemid 32467072)
151. Rosen KM, Veereshwarayya V, Moussa CE, Fu Q, Goldberg MS, Schlossmacher MG, Shen J, and Querfurth HW. Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem 281: 12809-12816, 2006. (Pubitemid 43855373)
152. Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, Ghosh J, Hsu CH, Segal L, Raghavan K, Matsumoto K, Hisamoto N, Kuwahara T, Iwatsubo T, Moore L, Goldstein L, Cookson M, and Wolozin B. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29: 9210-9218, 2009.
153. Sallinen V, Kolehmainen J, Priyadarshini M, Toleikyte G, Chen YC, and Panula P. Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 40: 93-101, 2010.
154. Samann J, Hegermann J, von Gromoff E, Eimer S, Baumeister R, and Schmidt E. Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J Biol Chem 284: 16482-16491, 2009.
155. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, Ahmad R, Miller DW, Zambrano I, Cowburn RF, Behbahani H, Cedazo-Minguez A, and Cookson MR. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS One 4: e5701, 2009.
156. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, and Toda T. Genomewide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307, 2009.
157. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990.
158. Schmidt S, Linnartz B, Mendritzki S, Sczepan T, Lü bbert M, Stichel CC, and Lü bbert H. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria. Hum Mol Genet 20: 1197-1211, 2011.
159. Sha D, Chin LS, and Li L. Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19: 352-363, 2010.
160. Shendelman S, Jonason A, Martinat C, Leete T, and Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2: e362, 2004.
161. Shiba K, Arai T, Sato S, Kubo S, Ohba Y, Mizuno Y, and Hattori N. Parkin stabilizes PINK1 through direct interaction. Biochem Biophys Res Commun 383: 331-335, 2009.
162. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, and Dawson TM. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144: 689-702, 2011.
163. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, and Casari G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492, 2005. (Pubitemid 41672130)
164. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, and Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312, 2009.
165. Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, and Ross CA. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9: 1231-1233, 2006. (Pubitemid 44454261)
166. Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, and Ross CA. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA 102: 18676-18681, 2005. (Pubitemid 43011285)
167. Song DD, Shults CW, Sisk A, Rockenstein E, and Masliah E. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186: 158-172, 2004. (Pubitemid 38333191)
168. Souza JM, Giasson BI, Chen Q, Lee VM, and Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 275: 18344-18349, 2000. (Pubitemid 30414790)
169. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388: 839-840, 1997.
170. Stichel CC, Zhu X-R, Bader V, Linnartz B, Schmidt S, and Lü bbert H. Mono-and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum Mol Genet 16: 2377-2393, 2007. (Pubitemid 47514484)
171. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, Gasser T, Wszolek Z, Mü ller T, Bornemann A, Wolburg H, Downward J, Riess O, Schulz JB, and Krü ger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14: 2099-2111, 2005. (Pubitemid 41418010)
172. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, and Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218, 2004. (Pubitemid 38401204)
173. Tanaka A. Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett 584: 1386-1392, 2010.
174. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, and Youle RJ. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191: 1367-1380, 2010.
175. Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, L. Dawson V, Dawson TM, and Ross CA. Inducible expression of mutant {alpha}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10: 919-926, 2001. (Pubitemid 32401408)
176. Terzioglu M and Galter D. Parkinson's disease: genetic versus toxin-induced rodent models. FEBS J 275: 1384-1391, 2008. (Pubitemid 351388790)
177. Thomas B and Beal MF. Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183-R194, 2007.
178. Thomas B, Mandir AS, West N, Liu Y, Andrabi SA, Stirling W, Dawson VL, Dawson TM, and Lee MK. Resistance to MPTP-neurotoxicity in a-synuclein knockout mice is complemented by human a-synuclein and associated with increased b-synuclein and akt activation. PLoS One 6: e16706, 2011.
179. Thomas B, von Coelln R, Mandir AS, Trinkaus DB, Farah MH, Leong Lim K, Calingasan NY, Flint Beal M, Dawson VL, and Dawson TM. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis 26: 312-322, 2007. (Pubitemid 46561335)
180. Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M, Sandebring A, Miller D, Maric D, Cedazo-Minguez A, and Cookson MR. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20: 40-50, 2011.
181. Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, Pothos EN, and Shen J. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci USA 106: 14622-14627, 2009.
182. Trancikova A, Ramonet D, and Moore DJ. Genetic mouse models of neurodegenerative diseases. Prog Mol Biol Transl Sci 100: 419-482, 2011.
183. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, and Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423, 2004. (Pubitemid 38715133)
184. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, and Wood NW. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160, 2004. (Pubitemid 38661852)
185. van der Brug MP, Blackinton J, Chandran J, Hao LY, Lal A, Mazan-Mamczarz K, Martindale J, Xie C, Ahmad R, Thomas KJ, Beilina A, Gibbs JR, Ding J, Myers AJ, Zhan M, Cai H, Bonini NM, Gorospe M, and Cookson MR. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci USA 105: 10244-10249, 2008.
186. Venderova K, Kabbach G, Abdel-Messih E, Zhang Y, Parks RJ, Imai Y, Gehrke S, Ngsee J, LaVoie MJ, Slack RS, Rao Y, Zhang Z, Lu B, Haque ME, and Park DS. Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease. Hum Mol Genet 18: 4390-4404, 2009.
187. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, and Przedborski S. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 107: 378-383, 2010.
188. von Coelln R, Dawson VL, and Dawson TM. Parkin-associated Parkinson's disease. Cell Tissue Res 318: 175-184, 2004. (Pubitemid 39362637)
189. Wang H, Song P, Du L, Tian W, Yue W, Liu M, Li D, Wang B, Zhu Y, Cao C, Zhou J, and Chen Q. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson's disease. J Biol Chem 286: 11649-11658, 2011.
190. Weihofen A, Ostaszewski B, Minami Y, and Selkoe DJ. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet 17: 602-616, 2008. (Pubitemid 351201772)
191. West AB and Maidment NT. Genetics of parkin-linked disease. Hum Genet 114: 327-336, 2004. (Pubitemid 38324945)
192. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, and Dawson TM. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102: 16842-16847, 2005. (Pubitemid 41688864)
193. West AB, Moore DJ, Choi C, Andrabi SA, Li X, Dikeman D, Biskup S, Zhang Z, Lim K-L, Dawson VL, and Dawson TM. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 16: 223-232, 2007. (Pubitemid 46179004)
194. Westermann B. Molecular Machinery of Mitochondrial Fusion and Fission. J Biol Chem 283: 13501-13505, 2008.
195. Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, and Pallanck LJ. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc Natl Acad Sci USA 102: 8024-8029, 2005. (Pubitemid 40781056)
196. Winslow AR, Chen C-W, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, Brown S, O'Kane CJ, and Rubinsztein DC. a-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 190: 1023-1037, 2010.
197. Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AY, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, Heales S, Duchen MR, Latchman D, Tabrizi SJ, and Wood NW. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One 3: e2455, 2008.
198. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi D-K, Ischiropoulos H, and Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22: 1763-1771, 2002. (Pubitemid 35386294)
199. Xiong Y, Coombes CE, Kilaru A, Li X, Gitler AD, Bowers WJ, Dawson VL, Dawson TM, and Moore DJ. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet 6: e1000902, 2010.
200. Xun Z, Sowell RA, Kaufman TC, and Clemmer DE. Lifetime proteomic profiling of an A30P a-synuclein Drosophila model of Parkinson's disease. J Proteome Res 6: 3729-3738, 2007. (Pubitemid 47522761)
201. Xun Z, Sowell RA, Kaufman TC, and Clemmer DE. Quantitative proteomics of a presymptomatic A53T alphasynuclein Drosophila model of Parkinson disease. Mol Cell Proteomics 7: 1191-1203, 2008. (Pubitemid 352038266)
202. Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, Yang L, Beal MF, Nishimura I, Wakamatsu K, Ito S, Takahashi R, and Lu B. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA 102: 13670-13675, 2005. (Pubitemid 41420906)
203. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, and Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103: 10793-10798, 2006. (Pubitemid 44078055)
204. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, and Lu B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 105: 7070-7075, 2008. (Pubitemid 351754531)
205. Yao Z and Wood NW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal 11: 2135-2149, 2009.
206. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, and Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342-1348, 2003. (Pubitemid 37490964)
207. Yu W, Matsuoka Y, Sziráki I, Hashim A, LaFrancois J, Sershen H, and Duff K. Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T a-synuclein. Neurochem Res 33: 902-911, 2008.
208. Zabetian CP, Yamamoto M, Lopez AN, Ujike H, Mata IF, Izumi Y, Kaji R, Maruyama H, Morino H, Oda M, Hutter CM, Edwards KL, Schellenberg GD, Tsuang DW, Yearout D, Larson EB, and Kawakami H. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord 24: 1034-1041, 2009.
209. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, Torp R, Torgner IA, Ottersen OP, Dawson TM, and Dawson VL. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14: 2063-2073, 2005. (Pubitemid 41418042)
210. Zhang L, Zhang C, Zhu Y, Cai Q, Chan P, Uéda K, Yu S, and Yang H. Semi-quantitative analysis of [alpha]-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody. Brain Res 1244: 40-52, 2008.
211. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, and Przedborski S. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci USA 105: 12022-12027, 2008.
212. Zhou H, Falkenburger BH, Schulz JB, Tieu K, Xu Z, and Xia XG. Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int J Biol Sci 3: 242-250, 2007. (Pubitemid 46425506)
213. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Mü ller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, and Gasser T. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44: 601-607, 2004. (Pubitemid 39531225)
214. Ziviani E, Tao RN, and Whitworth AJ. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci USA 107: 5018-5023, 2010.